Orchestra BioMed Holdings Inc. (OBIO) — Financial Flexibility Index
Orchestra BioMed Holdings Inc. (OBIO) has a Financial Flexibility Index of -0.23x as of September 2025. Free cash flow of $-14.24 Million (operating CF $-14.55 Million minus capex $310.00K) represents 0% of total liabilities ($61.07 Million). Also explore Orchestra BioMed Holdings Inc. net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Orchestra BioMed Holdings Inc. Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Orchestra BioMed Holdings Inc. across 5 annual periods. Check how strategically is Orchestra BioMed Holdings Inc.'s equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Orchestra BioMed Holdings Inc. (2020–2024)
Year-by-year free cash flow to debt coverage for Orchestra BioMed Holdings Inc.. For the full company profile including market capitalisation, see market value of Orchestra BioMed Holdings Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.16x | $-50.27 Million | $-50.56 Million | $43.22 Million | ▲ +31.4% |
| 2023 | -1.69x | $-46.05 Million | $-46.13 Million | $27.17 Million | ▼ -154.2% |
| 2022 | -0.67x | $-28.70 Million | $-29.29 Million | $43.04 Million | ▼ -195.1% |
| 2021 | -0.23x | $-19.16 Million | $-19.43 Million | $84.76 Million | ▲ +23.7% |
| 2020 | -0.30x | $-25.64 Million | $-26.18 Million | $86.63 Million | — |